Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.34 EUR
7.79 M EUR
141.92 M EUR
14.72 M
About JAPAN MEDICAL DYNAMIC MARKETING
Sector
Industry
Website
Headquarters
Tokyo
Founded
1973
ISIN
JP3689100000
FIGI
BBG000DRRMQ9
Japan Medical Dynamic Marketing, Inc. engages in the development, manufacture, import and sale of medical equipment. Its products include trauma devices, joint prostheses, spinal fixation devices, and artificial bone fillers. It also provides introduction of medical products to major hospitals and doctors nationwide. The firm operates through following geographical segments: Japan and US. The company was founded on May 28, 1973 and is headquartered in Tokyo, Japan.
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange JP.MEDICAL DY.MARK. stocks are traded under the ticker JMD.
Yes, you can track JP.MEDICAL DY.MARK. financials in yearly and quarterly reports right on TradingView.
JP.MEDICAL DY.MARK. is going to release the next earnings report on Apr 30, 2025. Keep track of upcoming events with our Earnings Calendar.
JP.MEDICAL DY.MARK. revenue for the last quarter amounts to 40.80 M EUR, despite the estimated figure of 39.34 M EUR. In the next quarter, revenue is expected to reach 41.55 M EUR.
JMD net income for the last quarter is 2.35 M EUR, while the quarter before that showed 1.39 M EUR of net income which accounts for 68.74% change. Track more JP.MEDICAL DY.MARK. financial stats to get the full picture.
JP.MEDICAL DY.MARK. dividend yield was 1.90% in 2023, and payout ratio reached 28.98%. The year before the numbers were 1.25% and 24.06% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 27, 2025, the company has 511 employees. See our rating of the largest employees — is JP.MEDICAL DY.MARK. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JP.MEDICAL DY.MARK. EBITDA is 21.25 M EUR, and current EBITDA margin is 14.42%. See more stats in JP.MEDICAL DY.MARK. financial statements.
Like other stocks, JMD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JP.MEDICAL DY.MARK. stock right from TradingView charts — choose your broker and connect to your account.